Novo Nordisk A/s
Clinical trials sponsored by Novo Nordisk A/s, explained in plain language.
-
New diabetes pill rybelsus under Real-World safety check in korea
Disease control Not yet recruitingThis study will follow 600 adults with type 2 diabetes who are starting Rybelsus (a daily pill) as part of their normal treatment. The goal is to track any side effects and how well the medicine controls blood sugar over about 26 weeks. Participants take the drug as their doctor …
Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Apr 27, 2026 21:01 UTC
-
New weekly shot aims to tackle both obesity and diabetes in one go
Disease control Not yet recruitingThis study tests a new once-weekly injection called NNC0487-0111 in 630 adults who are overweight or obese and have type 2 diabetes. Participants will receive either the study drug or a placebo for several weeks. The main goal is to see how much weight they lose, with additional …
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Apr 26, 2026 20:03 UTC